Ectoparasitic infestations
Drug research and approvals for ectoparasitic infestations: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 3 studies of ectoparasitic infestations are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 3
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 3 recruiting on ClinicalTrials.gov ↗
- Safety, Efficacy and Preventative Effect of a Head Lice Product (X92001483) vs. Nix Creme Rinse (1% Permethrin).NCT07660354 · Not applicable · Oystershell NV · starts May 1, 2026
- Better Options for Lymphatic Filariasis TreatmentNCT07159373 · Phase 3 · Medicines Development for Global Health · starts Sep 28, 2026
- Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical…NCT07145736 · Phase 4 · Kirby Institute · starts Aug 4, 2025
Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications
Approved 14
- PermethrinVoltage-sensitive sodium channel blocker
- DisulfiramAldehyde dehydrogenase inhibitor
- LindaneGABA-A receptor negative allosteric modulator
- Phenothrin
- Bioallethrin
- Tetramethrin
- Pyrethrum extractVoltage-sensitive sodium channel alpha-subunit blocker
- MalathionAcetylcholinesterase inhibitor
- Benzyl alcohol
- Benzyl benzoate
- Dimethicone
- AbametapirMetalloproteinase inhibitor
- Chlorophenothane
- Diethyltoluamide
Phase 3 2
- AlbendazoleTubulin inhibitor
- Retinol
Phase 2 3
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA